Text Size
27 studies found for:    pkd

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
pkd
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
2 Not yet recruiting LRRK2 Mutation and Parkinson's Disease
Condition: Parkinson Disease
Interventions: Genetic: Healthy;   Genetic: PKD Patients
3 Recruiting Pharmacogenomic Study on PKD/PKC of Dabigatran Etexilate and Rivaroxaban
Condition: Healthy Volunteers
Interventions: Drug: D->R->C+R;   Drug: D->R->C+D;   Drug: R->D->C+D;   Drug: R->D->C+R
4 Active, not recruiting HALT Progression of Polycystic Kidney Disease (HALT PKD)
Condition: Kidney, Polycystic
Interventions: Drug: Lisinopril and Placebo;   Drug: Lisinopril and Telmisartan
5 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
6 Recruiting Efficacy Study of Water Drinking on PKD Progression.
Conditions: Autosomal Dominant Polycystic Kidney Disease.;   Disease Progression
Intervention:
7 Unknown † High Water Intake to Slow Progression of Polycystic Kidney Disease
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Other: Water
8 Completed Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
Condition: Polycystic Kidney
Interventions: Drug: Sirolimus;   Drug: conventional therapy
9 Terminated Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
Condition: Advanced Cancer
Intervention: Drug: SGX523 Capsules
10 Completed Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: Water prescription
11 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
12 Recruiting A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: ADPKD Diet
13 Recruiting 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
14 Unknown † Clinical Trial to Slow the Progression of ADPKD
Conditions: Kidney, Polycystic;   Kidney, Polycystic, Autosomal Dominant
Intervention: Drug: anti-hypertensive medications
15 Completed Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Polycystic Kidney, Autosomal Dominant
Intervention:
16 Active, not recruiting Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes
Condition: Diabetic Kidney Disease
Intervention:
17 Terminated Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients
Condition: Infection Prophylaxis
Interventions: Drug: SAR279356;   Drug: placebo
18 Completed Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of SAR236553 (REGN727)
Condition: Hypercholesterolemia
Intervention: Drug: SAR236553/REGN727
19 Completed Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia
Condition: Sleep Initiation and Maintenance Disorders
Intervention: Drug: Eplivanserin (SR46349)
20 Completed Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Insulin glargine HOE901;   Drug: Insulin glargine - New formulation HOE901
To Top

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
† Indicates status has not been verified in more than two years